Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;71(4):1657-1658.
doi: 10.4103/IJO.IJO_2582_22.

Erlotinib-induced dry eye

Rashmita Ravisankar  1 , Arthi Mohankumar  2 , Narayana Shivananda  1
Affiliations

Erlotinib-induced dry eye

Rashmita Ravisankar et al. Indian J Ophthalmol. 2023 Apr.
No abstract available

Keywords: Dry eye; Erlotinib; tyrosine kinase inhibitors.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
(a) Diffuse slit-lamp image showing sparse eyelashes and blepharitis with decreased tear film height. (b) Diffuse slit-lamp image with cobalt blue filter showing punctate epithelial erosions on cornea
See this image and copyright information in PMC

References

    1. Genentech. Tarceva® (Erlotinib)-Information for Patients. [Last accessed on 2022 Sep 26]. Available from: https://www.gene.com/patients/medicines/tarceva .
    1. Methvin AB, Gausas RE. Newly recognized ocular side effects of erlotinib. Ophthal Plast Reconstr Surg. 2007;23:63–5. - PubMed
    1. Lane K, Goldstein SM. Erlotinib-associated trichomegaly. Ophthal Plast Reconstr Surg. 2007;23:65–6. - PubMed
    1. Celik T, Kosker M. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: A case report and review of the literature. Cont Lens Anterior Eye. 2015;38:59–60. - PubMed
    1. Yang QC, Bao J, Li C, Tan G, Wu AH, Ye L, et al. Amurine model of dry eye induced by topical administration of erlotinib eye drops. Int J Mol Med. 2018;41:1427–36. - PMC - PubMed

MeSH terms

Substances